bromocriptine has been researched along with angiotensin ii in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (69.23) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, BJ; Steiner, M | 1 |
| Birkhäuser, M; Riondel, A; Vallotton, MB | 1 |
| Carey, RM; Ortt, EM; Thorner, MO | 1 |
| Mason, PA; Semple, PF | 1 |
| Georgiev, V; Kambourova, T; Petkova, B | 1 |
| Liberini, P; Memo, M; Missale, C; Spano, P | 1 |
| Canonico, PL | 1 |
| Login, IS; Trugman, JM | 1 |
| Jarvis, WD; Judd, AM; MacLeod, RM | 1 |
| Mellinger, RC; Wisgerhof, M | 1 |
| Canonico, PL; Jarvis, WD; Judd, AM; MacLeod, RM | 1 |
| Mazzocchi, G; Nussdorfer, GG; Rebuffat, P; Robba, C | 1 |
| Belloni, AS; Gottardo, G; Mazzocchi, G; Meneghelli, V; Nussdorfer, GG; Rebuffat, P; Robba, C; Stachowiak, A | 1 |
| Fregly, MJ | 1 |
| Beck, FW; Sowers, JR | 2 |
| Golub, MS; Sowers, JR; Tuck, ML; Whitfield, L | 1 |
| Armato, U; Mantero, F | 1 |
| Doyle, AE; Hutchinson, JS | 1 |
| Bélisle, S; Petit, A; Vaillancourt, C | 1 |
| Komissarenko, IV; Markov, VV; Oleĭnik, VA; Rudichenko, VM; Slavnov, VN | 1 |
| Avery, LM; Grosvenor, CE; Kacsóh, B; Tóth, BE | 1 |
| Abdul-Wahab, R; Hussain, T; Kotak, DK; Lokhandwala, MF | 1 |
| Achával-Zaia, R; Becu-Villalobos, D; De Nicola, AF; Díaz-Torga, G; González Iglesias, A; Libertun, C; Piroli, G | 1 |
| Li, H; Li, HZ; Li, QF; Shi, S; Sun, YH; Wang, R; Xu, CQ; Zhao, YJ | 1 |
| Chlorou, A; Kotsa, K; Mediskou, P; Papazisi, A; Psarakou-Gotzamani, A; Tsekmekidou, X; Yavropoulou, MP; Yovos, JG | 1 |
1 review(s) available for bromocriptine and angiotensin ii
| Article | Year |
|---|---|
The psychobiology of premenstrual dysphoria: review of theories and treatments.
Topics: Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Angiotensin II; Bromocriptine; Diuretics; Estrogens; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Lithium; Luteinizing Hormone; Menstruation; Monoamine Oxidase; Premenstrual Syndrome; Progesterone; Prolactin; Pyridoxine; Renin; Testosterone; Vitamin B Deficiency | 1977 |
1 trial(s) available for bromocriptine and angiotensin ii
| Article | Year |
|---|---|
The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia.
Topics: Adult; Aldosterone; Angiotensin II; Bromocriptine; Creatinine; Dopamine Agonists; Female; Humans; Hydrocortisone; Hyperprolactinemia; Prolactin; Radioimmunoassay; Renin; Renin-Angiotensin System; Sodium | 2011 |
24 other study(ies) available for bromocriptine and angiotensin ii
| Article | Year |
|---|---|
Bromocriptine-induced modulation of plasma aldosterone response to acute stimulations.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Body Weight; Bromocriptine; Electrolytes; Humans; Hydrocortisone; Infusions, Parenteral; Male; Posture; Prolactin; Renin | 1979 |
Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Topics: 11-Hydroxycorticosteroids; Adult; Aldosterone; Angiotensin II; Blood Pressure; Bromocriptine; Dopamine; Humans; Kinetics; Male; Metoclopramide; Potassium; Prolactin; Renin; Sodium | 1979 |
Bromocriptine: lack of effect on the angiotensin II and aldosterone responses to sodium deprivation.
Topics: 18-Hydroxycorticosterone; Adult; Aldosterone; Angiotensin II; Bromocriptine; Diet, Sodium-Restricted; Female; Humans; Male; Potassium; Renin; Sodium | 1978 |
Effect of AT II on the exploratory behaviour of rats. Interactions with elymoclavine and bromocryptine.
Topics: Angiotensin II; Animals; Behavior, Animal; Bromocriptine; Ergolines; Exploratory Behavior; Male; Motor Activity; Rats; Rats, Inbred Strains | 1991 |
Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Benzazepines; Bromocriptine; Butaclamol; Cyclic AMP; Dopamine; Haloperidol; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1988 |
D-2 dopamine receptor activation reduces free [3H]arachidonate release induced by hypophysiotropic peptides in anterior pituitary cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylate Cyclase Toxin; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Benzazepines; Bromocriptine; Cells, Cultured; Dihydroergotoxine; Dopamine; Dopamine Antagonists; Female; Indomethacin; Kinetics; Masoprocol; Pertussis Toxin; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride; Tritium; Virulence Factors, Bordetella | 1989 |
The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells.
Topics: Angiotensin II; Animals; Bromocriptine; Colforsin; Cyclic AMP; Dopamine Antagonists; Female; Haloperidol; In Vitro Techniques; Oxazines; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone | 1989 |
Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor.
Topics: 1-Phosphatidylinositol 4-Kinase; Angiotensin II; Animals; Bombesin; Bromocriptine; Dopamine; Female; Growth Hormone; Inositol; Kinetics; Neurotensin; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphatidylinositols; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Somatostatin; Thyrotropin-Releasing Hormone | 1988 |
Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Bromocriptine; Humans; Hyperaldosteronism; Male; Middle Aged; Potassium | 1985 |
Dopamine does not attenuate phosphoinositide hydrolysis in rat anterior pituitary cells.
Topics: Angiotensin II; Animals; Bromocriptine; Cell Membrane; Cells, Cultured; Dopamine; Female; Hydrolysis; Inositol Phosphates; Neurotensin; Phosphatidylinositols; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Thyrotropin-Releasing Hormone | 1986 |
Long-term trophic effect of sodium restriction on the rat adrenal zona glomerulosa. II. The possible involvement of the inhibition of the dopaminergic system.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Bromocriptine; Captopril; Diet, Sodium-Restricted; Dopamine; Endoplasmic Reticulum; Hypertrophy; Metoclopramide; Mitochondria; Potassium; Rats; Rats, Inbred Strains; Sodium | 1988 |
Investigations on the possible involvement of the dopaminergic system in the modulation of the growth and steroidogenic capacity of the rat adrenal zona glomerulosa: a coupled morphometric and biochemical study.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Bromocriptine; Captopril; Male; Metoclopramide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Renin; Sodium | 1987 |
Effect of acute administration of bromocriptine on isoproterenol- and angiotensin II-induced water intake in estrogen-treated rats.
Topics: Angiotensin II; Animals; Bromocriptine; Drinking Behavior; Estradiol; Estrogen Antagonists; Female; Isoproterenol; Rats; Rats, Inbred Strains | 1987 |
Role of dopamine in the regulation of aldosterone and 18-hydroxycorticosterone secretion in man.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Bromocriptine; Corticosterone; Dopamine; Electrolytes; Furosemide; Humans; Hydrocortisone; Isometric Contraction; Male; Posture | 1984 |
Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in normal man.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Bromocriptine; Humans; Isometric Contraction; Kinetics; Male; Norepinephrine; Posture; Renin | 1980 |
Dopaminergic modulation of corticosteroid responses to angiotensin II in man.
Topics: 11-Hydroxycorticosteroids; 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Bromocriptine; Corticosterone; Desoxycorticosterone; Dopamine; Drug Interactions; Hormones; Humans; Hydrocortisone; Male; Mineralocorticoid Receptor Antagonists | 1983 |
Primary tissue culture of human adrenocortical Conn's adenomata. Bromocriptine as a possible agonist-antagonist of angiotensin at the cellular level.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Angiotensin II; Bromocriptine; Cells, Cultured; Culture Techniques; DNA Replication; Drug Interactions; Humans; Mitotic Index; Transcription, Genetic | 1984 |
Hypotensive effects of captopril, saralasin and bromocriptine in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Bromocriptine; Captopril; Dopamine; Hypertension; In Vitro Techniques; Oxytocin; Pituitary Gland, Posterior; Proline; Rats; Saralasin; Swine; Vasopressins | 1980 |
Inhibition of angiotensin II-stimulated inositol phosphate production by D2-dopamine receptor is calcium-dependent in human trophoblastic cells.
Topics: Angiotensin II; Bromocriptine; Calcium; Cells, Cultured; Colforsin; Cyclic AMP; Dopamine; Humans; In Vitro Techniques; Inositol Phosphates; Nifedipine; Receptors, Dopamine D2; Trophoblasts | 1995 |
[The effect of the one-time and long-term administration of preparations acting on biogenic amine metabolism on the blood level of pressor peptide hormones].
Topics: Adolescent; Adult; Angiotensin II; Biogenic Amines; Blood Pressure; Bromocriptine; Chronic Disease; Cyproheptadine; Drug Evaluation; Female; Humans; Hypertension; Hypothalamic Diseases; Male; Middle Aged; Syndrome; Time Factors; Vasopressins | 1993 |
In vitro control of prolactin (PRL) and growth hormone secretion of neonatal rat pituitary glands: effects of ovine PRL, salmon calcitonin, endothelin-3, angiotensin II, bromocryptine and somatostatin.
Topics: Angiotensin II; Animals; Animals, Newborn; Bromocriptine; Calcitonin; Endothelins; Female; Growth Hormone; Male; Organ Culture Techniques; Pituitary Gland; Prolactin; Rats; Sheep; Somatostatin | 1993 |
Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules.
Topics: Angiotensin II; Animals; Bromocriptine; Cyclic AMP; Dopamine Agents; Enzyme Activation; GTP-Binding Proteins; Kidney Tubules, Proximal; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium-Potassium-Exchanging ATPase | 1998 |
Bromocriptine restores angiotensin II response in pituitary hyperplasia.
Topics: Angiotensin II; Animals; Bromocriptine; Calcium; Calcium Channels; Diethylstilbestrol; Female; Hyperplasia; Immunohistochemistry; In Vitro Techniques; Pituitary Gland; Potassium; Prolactin; Rats; Rats, Sprague-Dawley; Thapsigargin | 2000 |
Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Bromocriptine; Calcium Signaling; Cardiomegaly; Cells, Cultured; Dopamine Agonists; Dopamine Antagonists; Endothelin-1; Haloperidol; Heart Ventricles; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phosphorylation; Protein Kinase C; Rats; Rats, Wistar; Receptors, Dopamine D2 | 2009 |